Botulinum toxin type A in simple motor tics: Short-term and long-term treatment-effects

Parkinsonism and Related Disorders

Volumn 16, Issue 7, 2010, Pages 478-481

  Rath, Judith J G ^a   Tavy, Dénes L J ^a   Wertenbroek, Agnes A A C M ^a   van Woerkom, Theodoor C A M ^a   de Bruijn, Sebastiaan F T M ^a  

^a HAGA HOSPITAL   (Netherlands)

Author keywords

Botulinum toxin; Efficacy; Long term; Premonitory urge; Tics

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; EXTRAOCULAR MUSCLE; FACE DISORDER; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; HUMAN; LATENT PERIOD; LONG TERM CARE; MALE; MUSCLE WEAKNESS; NECK MUSCLE; PRIORITY JOURNAL; RELAPSE; REMISSION; SHORT COURSE THERAPY; TIC; TREATMENT DURATION; TREATMENT OUTCOME; ADOLESCENT; DRUG EFFECTS; MIDDLE AGED; REACTION TIME; RETROSPECTIVE STUDY; TICS; TIME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BOTULINUM TOXIN TYPE A; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; REACTION TIME; RETROSPECTIVE STUDIES; TICS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT; BOTULINUM TOXINS, TYPE A;

EID: 77954956290     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2009.11.011     Document Type: Article

References (12)

1. Albin R.L., Mink J.W. Recent advances in Tourette syndrome research. Trends Neurosci 2006, 29:175-182.
2. Jankovic J. Botulinum toxin in the treatment of dystonic tics. Move Disord 1994, 9:347-349.
3. Marras C., Andrews D., Sime E., Lang A.E. Botulinum toxin for simple motor tics. Neurology 2001, 56:605-610.
4. Kwak C.H., Hanna P.A., Jankovic J. Botulinum toxin in the treatment of tics. Arch Neurol 2000, 57:1190-1193.
5. Awaad Y. Tics in Tourette syndrome: new treatment options. J Child Neurol 1999, 14:316-319.
6. Hsiung G.Y., Das S.K., Ranawaya R., Lafontaine A.L., Suchowersky O. Long-term efficacy of botulinum toxin type A in treatment of various movement disorders over a 10-year period. Move Disord 2002, 17:1288-1293.
7. Lerner A., Bagic A., Boudreau E.A., et al. Neuroimaging of neuronal circuits involved in tic generation in patients with Tourette syndrome. Neurology 2007, 68:1979-1987.
8. Rosales R.L., Arimura K., Takenaga S., Osame M. Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection. Muscle & Nerve 1996, 19:488-496.
9. Ranoux D., Attal N., Morain F., Bouhasisra D. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. Ann Neurol 2008, 64:274-284.
10. Arezzo J.C. Possible mechanisms for the effects of botulinum toxin on pain. Clin J Pain 2002, 18:S125-S132.
11. Borodic G.E., Ferrante R. Effects of repeated botulinum toxin injections on orbicularis oculi muscle. J Clin Neuro Ophthalmol 1992, 12:121-127.
12. Jankovic J., Schwartz K.S. Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia. Neurology 1993, 43:834-836.